|
| Status |
Public on Jun 01, 2022 |
| Title |
RNA-seq of detecting the effect of CDK4&6 inhibitor Abemaciclib and VSV-M51 in glioma |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
The RNA-seq data provided evidence that CDK4&6 inhibitor Abemaciclib and VSV-M51 increase the oncolytic effect in glioma
|
| |
|
| Overall design |
Setting three groups, control, VSV-M51, CDK4&6 inhibitor Abemaciclib and VSV-M51. CDK4&6 inhibitor Abemaciclib pretreat the T98 human glioma cells, then using the VSV-M51 oncolytic virus infect the T98 cells for 24 hours. Collected the three groups cells by trizol.
|
| |
|
| Contributor(s) |
Jingshu X |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Feb 17, 2021 |
| Last update date |
Jun 01, 2022 |
| Contact name |
Ping Li |
| E-mail(s) |
liping53@mail2.sysu.edu.cn
|
| Phone |
13242804006
|
| Organization name |
Sun Yat-sen University
|
| Department |
School of Medicine
|
| Lab |
Guo
|
| Street address |
Gongchang Road
|
| City |
Shenzhen |
| ZIP/Postal code |
518107 |
| Country |
China |
| |
|
| Platforms (1) |
|
| Samples (9)
|
|
| Relations |
| BioProject |
PRJNA702285 |
| SRA |
SRP306807 |
Less...
More...